Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Sibley

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Magma (New York, N.Y.)|August 21, 2024
Deep learning applications for quantitative and qualitative PET in PET/MR: technical and clinical unmet needsJaewon Yang, Asim Afaq, Robert Sibley, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2003
A novel estrogen receptor ligand templateRobert Sibley, Holia Hatoum-Mokdad, Robert Schoenleber, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Discovery of a Series of Pyrazinone RORγ Antagonists and Identification of the Clinical Candidate BI 730357Christian Harcken, Johanna Csengery, Michael Turner, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2005
4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 2. SARDavid Gunn, Christiana Akuche, Jeremy Baryza, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Magma (New York, N.Y.)|August 21, 2024
Deep learning applications for quantitative and qualitative PET in PET/MR: technical and clinical unmet needsJaewon Yang, Asim Afaq, Robert Sibley, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2003
A novel estrogen receptor ligand templateRobert Sibley, Holia Hatoum-Mokdad, Robert Schoenleber, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Discovery of a Series of Pyrazinone RORγ Antagonists and Identification of the Clinical Candidate BI 730357Christian Harcken, Johanna Csengery, Michael Turner, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2005
4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 2. SARDavid Gunn, Christiana Akuche, Jeremy Baryza, et al.
Pageof 1